Atrium Innovations Inc:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Atrium Innovations Inc - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C3310
◆発行会社(調査会社):GlobalData
◆発行日:2018年8月
◆ページ数:22
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:カナダ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Atrium Innovations Inc (Atrium) is a provider of science-based natural health products. The company develops, manufactures and markets nutritional and dietary supplements. Its major products include minerals, vitamins and specialized products such as enzymes and probiotics. Atrium markets its products under brands such as Garden of Life, Klean Athlete, Minami and Orthica, among others. It has partnerships with academic institutes such as Institute of Nutrition and Functional Foods at Laval University; Cleveland Clinic Center for Functional Medicine and other commercial partners. The company also supports research projects at academic centers across the world. The company has manufacturing facilities in the US, Canada, Europe and Argentina. Atrium is headquartered in Quebec, Canada.

Atrium Innovations Inc – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atrium Innovations Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deal Details 10
Private Equity 10
Permira Funds Completes Acquisition Of Atrium Innovations For US$1.04 Billion 10
Partnerships 13
Atrium Innovations Forms Joint Venture With Fosun Industrial 13
Licensing Agreements 14
Atrium Innovations Enters Into Licensing Agreement With Juvenon 14
Acquisition 15
Nestle to Acquire Atrium Innovations for USD2.3 Billion 15
Atrium Innovations Acquires 70% Stake In Mucos Pharma 17
Atrium Innovations Inc – Key Competitors 18
Atrium Innovations Inc – Key Employees 19
Atrium Innovations Inc – Locations And Subsidiaries 20
Head Office 20
Other Locations & Subsidiaries 20
Joint Venture 21
Appendix 22
Methodology 22
About GlobalData 22
Contact Us 22
Disclaimer 22

List of Tables
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Key Facts 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atrium Innovations Inc, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atrium Innovations Inc, Deals By Therapy Area, 2012 to YTD 2018 8
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Permira Funds Completes Acquisition Of Atrium Innovations For US$1.04 Billion 10
Atrium Innovations Forms Joint Venture With Fosun Industrial 13
Atrium Innovations Enters Into Licensing Agreement With Juvenon 14
Nestle to Acquire Atrium Innovations for USD2.3 Billion 15
Atrium Innovations Acquires 70% Stake In Mucos Pharma 17
Atrium Innovations Inc, Key Competitors 18
Atrium Innovations Inc, Key Employees 19
Atrium Innovations Inc, Subsidiaries 20
Atrium Innovations Inc, Joint Venture 21

List of Figures
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Atrium Innovations Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Atrium Innovations Inc:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • ELITechGroup Inc:医療機器:M&Aディール及び事業提携情報
    Summary ELITechGroup Inc (ELITech) is a medical device company that manufactures and distributes in vitro diagnostic equipment and reagents. The company’s products portfolio includes clinical chemistry, cystic fibrosis, hematology, microbiology and molecular diagnostics. Its clinical chemistry produ …
  • T7 Global Bhd (T7GLOBAL):石油・ガス:M&Aディール及び事業提携情報
    Summary T7 Global Bhd (T7 Global), formerly Tanjung Offshore Berhad, is an oil and gas company that offers gas generators and integrated services. The company's services include topside maintenance, engineering and procurement, installation and commissioning, initial engineering design layout, proje …
  • Sanshin Electronics Co., Ltd.:企業の戦略・SWOT・財務分析
    Sanshin Electronics Co., Ltd. - Strategy, SWOT and Corporate Finance Report Summary Sanshin Electronics Co., Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and …
  • Pioneer Natural Resources Co (PXD):企業の財務・戦略的SWOT分析
    Pioneer Natural Resources Co (PXD) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Pan Pacific Hotels Group Ltd:企業の戦略・SWOT・財務分析
    Pan Pacific Hotels Group Ltd - Strategy, SWOT and Corporate Finance Report Summary Pan Pacific Hotels Group Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and s …
  • Terme Dobrna D.D.
    Terme Dobrna D.D. - Strategy, SWOT and Corporate Finance Report Summary Terme Dobrna D.D. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Concardis Gmbh:企業の戦略・SWOT・財務分析
    Concardis Gmbh - Strategy, SWOT and Corporate Finance Report Summary Concardis Gmbh - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpora …
  • InspireMD Inc (NSPR):企業の財務・戦略的SWOT分析
    Summary InspireMD Inc (InspireMD) is a medical device company that develops and commercializes embolic prevention systems and neurovascular devices. The company offers CGuard carotid embolic prevention systems for use in carotid artery applications; and MGuard prime embolic protection systems for us …
  • Audi AG (NSU):企業の財務・戦略的SWOT分析
    Audi AG (NSU) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the pot …
  • Y.S.P. Southeast Asia Holding Berhad (YSPSAH):企業の財務・戦略的SWOT分析
    Y.S.P. Southeast Asia Holding Berhad (YSPSAH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key stre …
  • Spectrum Pharmaceuticals Inc (SPPI)-製薬・医療分野:企業M&A・提携分析
    Summary Spectrum Pharmaceuticals Inc (Spectrum) is a biotechnology company that develops and commercializes a pipeline of late-stage clinical and commercial products with focus on hematology and oncology. The company’s marketed drugs include Fusilev (levoleucovorin); Folotyn (pralatrexate injection) …
  • Graftys SA:製品パイプライン分析
    Summary Graftys SA (Graftys) is a medical device company that focuses on the development, manufacture and commercialization of synthetic bioactive orthopedic biomaterials. It provides a wide range of synthetic and bioresorbable bone graft substitutes and other cement products. The company’s products …
  • Meritor, Inc. (MTOR):企業の財務・戦略的SWOT分析
    Meritor, Inc. (MTOR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Centogene AG:医療機器:M&Aディール及び事業提携情報
    Summary Centogene AG (Centogene) is a biotechnology and genetic diagnostic company which offers genetic testing for rare hereditary disorders. The company provides diagnostic services including whole genome sequencing, whole exome sequencing, clinical exome sequencing, NGS panel genomic, carrier scr …
  • Cosan S.A. Industria e Comercio (CSAN3):企業の財務・戦略的SWOT分析
    Cosan S.A. Industria e Comercio (CSAN3) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • Esco Technologies Inc (ESE):企業の財務・戦略的SWOT分析
    Esco Technologies Inc (ESE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakness …
  • RBC Wealth Management:企業の戦略・SWOT・財務分析
    RBC Wealth Management - Strategy, SWOT and Corporate Finance Report Summary RBC Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Perceptron Inc (PRCP):企業の財務・戦略的SWOT分析
    Summary Perceptron Inc (Perceptron) is a technology company that produces, develops, and markets automated industrial metrology products and solutions. The company’s products include dimensional inspection, robot guidance, dimensional gauging, gap and flush solutions, 3D scanning, and metrology soft …
  • Raysearch Laboratories AB (RAY B):企業の財務・戦略的SWOT分析
    Summary RaySearch Laboratories AB (RaySearch) is a medical technology company that develops software solutions for radiation therapy of cancer. The company provides software products such as rayplan, raystation and raycare. Its services include installation, support, training and training schedule. …
  • AroCell AB (AROC):製薬・医療:M&Aディール及び事業提携情報
    Summary AroCell AB (AroCell), formerly Xi Bao Research AB, is a drug development company that develops and commercializes tests used for the prognosis and monitoring of treatment of cancer. The company develops TK 210 ELISA kits for measuring the enzyme TK1 which is a protein that is elevated in the …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆